Session

Overview: This symposium “Radiation Biology of Targeted Radionuclide Therapy” will compare the (immunological) effects of targeted radionuclide therapy to that of external beam radiation therapy, and discuss the differences between alpha and beta radiation. Key topics in radiopharmaceutical development, radiation biology, and therapeutic advancements will be covered, including the radiopharmaceutical pipeline, theranostic applications, clinical translation, and patent considerations. Auger electrons will also be introduced, highlighting their therapeutic potential and recent research findings. Collectively, this symposium will offer valuable insights into the evolving field of targeted radiation therapies and their clinical impact.